If you liked this article you might like

Cramer: Nasdaq 6000 (the Number) vs. Nasdaq 2000 (the Year)
Novartis, Amgen Divvy Global Marketing of New Migraine Drug
American Companies, Even Those Critical of Trump, Gave Big Bucks to Inauguration
Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector